EV-to-FCF is calculated as enterprise value divided by its free cash flow. As of today, Devonian Health Group's Enterprise Value is $12.57 Mil.
Devonian Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 was $6.44 Mil. Therefore, Devonian Health Group's EV-to-FCF for today is 1.95.
The historical rank and industry rank for Devonian Health Group's EV-to-FCF or its related term are showing as below:
DVHGF'
s EV-to-FCF Range Over the Past 10 Years
Min: -48.11 Med: -12.14 Max: 3.52
Current: 1.61
During the past 11 years, the highest EV-to-FCF of Devonian Health Group was 3.52. The lowest was -48.11. And the median was -12.14.
DVHGF's EV-to-FCF is ranked better than 60.25% of 395
companies
in the Biotechnology industry
Industry Median: 7.5
vs DVHGF: 1.61
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Devonian Health Group's EV-to-FCF
For the Biotechnology subindustry, Devonian Health Group's EV-to-FCF, along with its competitors' market caps and EV-to-FCF data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Devonian Health Group's EV-to-FCF Distribution in the Biotechnology Industry
For the Biotechnology industry and Healthcare sector, Devonian Health Group's EV-to-FCF distribution charts can be found below:
* The bar in red indicates where Devonian Health Group's EV-to-FCF falls into.
Devonian Health Group's current Enterprise Value is $12.57 Mil.
Devonian Health Group's Free Cash Flow for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $6.44 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Devonian Health Group (OTCPK:DVHGF) EV-to-FCF Explanation
EV-to-FCF is a valuation multiple that allows analysts and investors to compare stocks, preferably in the same sector or industry. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Devonian Health Group's PE Ratio (TTM) for today is calculated as:
Devonian Health Group's share price for today is $0.1325.
Devonian Health Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.000.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Enterprise Value is used because it is a more complete measure in reflecting how much an investor pays when buying a company. Free Cash Flow is an important financial metric because it represents the actual amount of cash at a company's disposal. Companies with a low EV-to-FCF ratio, combined with a strong balance sheet are generally considered as undervalued.
Devonian Health Group EV-to-FCF Related Terms
Thank you for viewing the detailed overview of Devonian Health Group's EV-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
DVHGF has been successfully added to your 